Patent · US Active

CCR2 antagonist peptides

US9434766B2 · kind B2 · utility

2Cited by

0References

6Claims

0Family size

Assignee

Universite Pierre Et Marie Curie (Paris 6) · FR

Inventors

Christophe Combadiere · Paris, FR
Florian Sennlaub · Paris, FR
Constance Auvynet · Paris, FR
Sylvian Chemtob · Winnipeg, CA
Christiane Quiniou · Montréal, CA

Key dates

Filing date	Jun 26, 2012
Grant date	Sep 6, 2016
Priority date	—
Expiry date	Oct 12, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a peptide comprising the following amino acid sequence Thr-Phe-Leu-Lys (SEQ ID NO: 17) or Thr-Phe-Leu-Lys-Cys (SEQ ID NO: 1), useful as a CCR2 non-competitive antagonist peptide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.